Form 4: Corcept Therapeutics Executive Reports Stock Ownership Changes
SEC Form 4 Filing
Gary Charles Robb, Chief Business Officer of Corcept Therapeutics, reports changes in beneficial ownership of company stock, including shares held directly and indirectly through custodial accounts.
Summary
- Gary Charles Robb, the Chief Business Officer of Corcept Therapeutics, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On January 27, 2025, Robb acquired 313 shares of common stock indirectly through a custodial account for a child.
- He also reported directly owning 18,865 shares, which includes unvested restricted stock awards granted on June 3, 2024 (1,818 shares), September 3, 2024 (503 shares), December 2, 2024 (290 shares) and March 3, 2025 (292 shares).
- The restricted stock awards vest on the one-year anniversary of the grant date, contingent on Robb meeting certain requirements.
- Following the reported transactions, Robb beneficially owns 11,211 shares indirectly through a custodial account and 18,865 shares directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock ownership changes, with no inherent positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| June 3, 2024 | Grant date of 1,818 unvested restricted stock awards. |
| September 3, 2024 | Grant date of 503 unvested restricted stock awards. |
| December 2, 2024 | Grant date of 290 unvested restricted stock awards. |
| January 27, 2025 | Date of common stock transaction through custodial account. |
| March 3, 2025 | Grant date of 292 unvested restricted stock awards. |
| April 23, 2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, beneficial ownership, stock, Corcept Therapeutics, CORT, Gary Charles Robb, restricted stock awards, custodial account
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.